Tokyo Tape
Sign in
← Euglena

Quarterly report · Q2

2931.TEDINET S100OYUS
Period2022-01-01 → 2022-06-30
Filed2022-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks13 of 14 passed
Key figures · 45
MetricValuePeriodScopeSource row
Revenue¥21.6bn2022-01-01 → 2022-06-30Cons.Net sales
Revenue¥34.4bn2020-10-01 → 2021-12-31Cons.Net sales (5-year summary)
Revenue¥7.7bn2020-10-01 → 2021-03-31Cons.Net sales
Operating income−¥1.4bn2022-01-01 → 2022-06-30Cons.Operating income
Operating income−¥511m2020-10-01 → 2021-03-31Cons.Operating income
Ordinary income−¥597m2022-01-01 → 2022-06-30Cons.Ordinary income
Ordinary income−¥6.4bn2020-10-01 → 2021-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥130m2020-10-01 → 2021-03-31Cons.Ordinary income
Profit before tax−¥595m2022-01-01 → 2022-06-30Cons.Income before income taxes
Profit before tax−¥117m2020-10-01 → 2021-03-31Cons.Income before income taxes
Net income (owners)−¥465m2022-01-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥5.0bn2020-10-01 → 2021-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥196m2020-10-01 → 2021-03-31Cons.Profit loss attributable to owners of parent
Net income−¥462m2022-01-01 → 2022-06-30Cons.Profit loss
Net income−¥194m2020-10-01 → 2021-03-31Cons.Profit loss
Total assets¥58.6bnat 2022-06-30Cons.Assets
Total assets¥61.0bnat 2021-12-31Cons.Assets
Total assets¥21.7bnat 2021-03-31Cons.Total assets (5-year summary)
Total liabilities¥38.8bnat 2022-06-30Cons.Liabilities
Total liabilities¥40.4bnat 2021-12-31Cons.Liabilities
Net assets / equity¥19.9bnat 2022-06-30Cons.Net assets
Net assets / equity¥20.6bnat 2021-12-31Cons.Net assets
Net assets / equity¥11.1bnat 2021-03-31Cons.Net assets (5-year summary)
Cash and deposits¥9.5bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥9.9bnat 2021-12-31Cons.Cash and deposits
Cash & equivalents¥9.3bnat 2022-06-30Cons.Cash and cash equivalents
Cash & equivalents¥9.8bnat 2021-12-31Cons.Cash and cash equivalents
Cash & equivalents¥4.2bnat 2021-03-31Cons.Cash and cash equivalents
Operating cash flow¥1.1bn2022-01-01 → 2022-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥1.4bn2020-10-01 → 2021-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥362m2020-10-01 → 2021-03-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥531m2022-01-01 → 2022-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥10.3bn2020-10-01 → 2021-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥5.9bn2020-10-01 → 2021-03-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥1.1bn2022-01-01 → 2022-06-30Cons.Net cash provided by used in financing activities
Financing cash flow¥12.1bn2020-10-01 → 2021-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥3.1bn2020-10-01 → 2021-03-31Cons.Net cash provided by used in financing activities
EPS (basic)¥-4.182022-01-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-4.542022-04-01 → 2022-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-49.072020-10-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-2.12020-10-01 → 2021-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥1.762021-01-01 → 2021-03-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio33.1%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio33.0%at 2021-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio51.0%at 2021-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 26
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-06-30−¥810m
jpcrp040300-q2r_E27054-000Biofuel Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥63m
jpcrp040300-q2r_E27054-000Biofuel Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥63m
jpcrp040300-q2r_E27054-000Biofuel Businessreportable segmentsegment profit2022-01-01 → 2022-06-30−¥376m
jpcrp040300-q2r_E27054-000Health Care Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥20.2bn
jpcrp040300-q2r_E27054-000Health Care Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥20.2bn
jpcrp040300-q2r_E27054-000Health Care Businessreportable segmentsegment profit2022-01-01 → 2022-06-30−¥122m
jpcrp040300-q2r_E27054-000Others Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥1.3bn
jpcrp040300-q2r_E27054-000Others Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥1.3bn
jpcrp040300-q2r_E27054-000Others Businessreportable segmentsegment profit2022-01-01 → 2022-06-30−¥113m
Total Of Reportable Segments And Otherssegment totalrevenue2022-01-01 → 2022-06-30¥21.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-01-01 → 2022-06-30¥21.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-01-01 → 2022-06-30−¥611m
Reconciling Itemsreconcilingsegment profit2020-10-01 → 2021-03-31−¥697m
jpcrp040300-q2r_E27054-000Biofuel Businessreportable segmentrevenue2020-10-01 → 2021-03-31¥5m
jpcrp040300-q2r_E27054-000Biofuel Businessreportable segmentrevenue external2020-10-01 → 2021-03-31¥5m
jpcrp040300-q2r_E27054-000Biofuel Businessreportable segmentsegment profit2020-10-01 → 2021-03-31−¥295m
jpcrp040300-q2r_E27054-000Health Care Businessreportable segmentrevenue2020-10-01 → 2021-03-31¥7.4bn
jpcrp040300-q2r_E27054-000Health Care Businessreportable segmentrevenue external2020-10-01 → 2021-03-31¥7.4bn
jpcrp040300-q2r_E27054-000Health Care Businessreportable segmentsegment profit2020-10-01 → 2021-03-31¥624m
jpcrp040300-q2r_E27054-000Others Businessreportable segmentrevenue2020-10-01 → 2021-03-31¥288m
jpcrp040300-q2r_E27054-000Others Businessreportable segmentrevenue external2020-10-01 → 2021-03-31¥288m
jpcrp040300-q2r_E27054-000Others Businessreportable segmentsegment profit2020-10-01 → 2021-03-31−¥143m
Total Of Reportable Segments And Otherssegment totalrevenue2020-10-01 → 2021-03-31¥7.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2020-10-01 → 2021-03-31¥7.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2020-10-01 → 2021-03-31¥185m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 595
ItemContextValueUnit
Salaries and allowances sgaPrior1YTDDuration632000000JPY
Salaries and allowances sgaCurrentYTDDuration1398000000JPY
Advertising expenses sgaPrior1YTDDuration2043000000JPY
Advertising expenses sgaCurrentYTDDuration5407000000JPY
Research and development expenses sgaPrior1YTDDuration442000000JPY
Research and development expenses sgaCurrentYTDDuration729000000JPY
Depreciation sgaPrior1YTDDuration148000000JPY
Depreciation sgaCurrentYTDDuration957000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E27054-000HealthCareBusinessReportableSegmentsMember7443000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E27054-000BiofuelBusinessReportableSegmentsMember5000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E27054-000OthersBusinessReportableSegmentsMember288000000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember7737000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration7737000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E27054-000HealthCareBusinessReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E27054-000BiofuelBusinessReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E27054-000OthersBusinessReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember－JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember－JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E27054-000HealthCareBusinessReportableSegmentsMember7443000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E27054-000BiofuelBusinessReportableSegmentsMember5000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E27054-000OthersBusinessReportableSegmentsMember288000000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember7737000000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember－JPY
Net salesPrior1YTDDuration7737000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E27054-000HealthCareBusinessReportableSegmentsMember624000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E27054-000BiofuelBusinessReportableSegmentsMember-295000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E27054-000OthersBusinessReportableSegmentsMember-143000000JPY
Operating incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember185000000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember-697000000JPY
Operating incomePrior1YTDDuration-511000000JPY
Direct salesCurrentYTDDuration_jpcrp040300-q2r_E27054-000HealthCareBusinessReportableSegmentsMember17320000000JPY
Direct salesCurrentYTDDuration_jpcrp040300-q2r_E27054-000BiofuelBusinessReportableSegmentsMember－JPY
Direct salesCurrentYTDDuration_jpcrp040300-q2r_E27054-000OthersBusinessReportableSegmentsMember－JPY
Direct salesCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember17320000000JPY
Direct salesCurrentYTDDuration_ReconcilingItemsMember－JPY
Direct salesCurrentYTDDuration17320000000JPY
DistributionCurrentYTDDuration_jpcrp040300-q2r_E27054-000HealthCareBusinessReportableSegmentsMember1882000000JPY
DistributionCurrentYTDDuration_jpcrp040300-q2r_E27054-000BiofuelBusinessReportableSegmentsMember－JPY
DistributionCurrentYTDDuration_jpcrp040300-q2r_E27054-000OthersBusinessReportableSegmentsMember－JPY
DistributionCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember1882000000JPY
DistributionCurrentYTDDuration_ReconcilingItemsMember－JPY
DistributionCurrentYTDDuration1882000000JPY
Original equipment manufacturing material overseasCurrentYTDDuration_jpcrp040300-q2r_E27054-000HealthCareBusinessReportableSegmentsMember629000000JPY
Original equipment manufacturing material overseasCurrentYTDDuration_jpcrp040300-q2r_E27054-000BiofuelBusinessReportableSegmentsMember－JPY
Original equipment manufacturing material overseasCurrentYTDDuration_jpcrp040300-q2r_E27054-000OthersBusinessReportableSegmentsMember－JPY
Original equipment manufacturing material overseasCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember629000000JPY
Original equipment manufacturing material overseasCurrentYTDDuration_ReconcilingItemsMember－JPY
Original equipment manufacturing material overseasCurrentYTDDuration629000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 14 passed
balance sheet identityconsolidated 2021-12-31pass rounding
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution partial
statement vs summary · net assetsconsolidated 2021-12-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2020-10-01/2021-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2020-10-01/2021-03-31pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-06-30pass
statement vs summary · revenueconsolidated 2020-10-01/2021-03-31pass
statement vs summary · revenueconsolidated 2022-01-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2021-12-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass